Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.

Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Kyowa Kirin, engages in the manufacture and sale of medical products and pharmaceuticals in the therapeutic areas of nephrology, oncology, and immunology in Japan. Its pharmaceutical products include GRAN, a protein that enables a quick recovery from neutropenia and reduces the risk of infection; NESP, an agent for correcting anemia; ESPO, a glycoprotein, which acts as an anemia-relieving treatment for dialysis patients; and CONIEL, a calcium antagonist agent for hypertension and angina pectoris. The company's pharmaceutical products also comprise REGPARA an agent for the treatment of secondary hyperparathyroidism; ALLELOCK/Patanol, which are used as medicine for patients with various types of allergies; and DEPAKENE/TOPINA, antiepileptic agents. It also offers a range of products, including amino acids, nucleic acids, vitamins, and sugars, which are used to produce pharmaceuticals, health foods, foods, cosmetics, and other products; plant growth regulators, feed additives, companion animal-related products, and aquaculture medicinal products; and various types of alcohol for use in alcoholic beverages. In addition, the company manufactures and sells industrial alcohols and solvents for automotive, electronics, and housing industries; performance materials that enable the production of raw materials for lubricants, higher alcohols, and polymeric materials used in various consumer goods; and a range of electronic materials for the information technology industry. Further, it provides seasonings, sweeteners, freeze-dried products, and bakery products and ingredients. The company was founded in 1885 and is headquartered in Tokyo, Japan. Kyowa Hakko Kirin Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited.

The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and\nother related life-threatening illnesses.

The National Institute of Water and Atmospheric Research or NIWA (Māori: Taihoro Nukurangi), is a Crown Research Institute of New Zealand. Established in 1992, NIWA conducts research across a broad range of disciplines in the environmental sciences. It also maintains nationally and, in some cases, internationally important environmental monitoring networks, databases, and collections.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Victoria Link Ltd. is a company headquartered in Hong Kong, Hong Kong, providing investment services.

Jellatech is a B2B biotech business based in Raleigh, NC, and with R&D in Wageningen, Netherlands. Jellatech is producing high-quality, pure, animal-free collagen and gelatin. Founded by a group of innovators, dreamers, entrepreneurs, and scientists, Jellatech is eliminating the dependency on animals, to make better ingredient products - starting with collagen and gelatin.

The Life Ark is focusing on the storage and application of immune cells and integrates R&D, production, and marketing. The company is a core API manufacturer of innovative cell drugs , mainly engaged in the development of large-scale preparation reagents for immune cells, especially NK cells in vitro. As one of the earliest immune cell research companies in China, Zhongying Bio has 35 invention patents , and has ensured its leading position in the industry with advanced technology.

Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

Shanghai Jiangnan Changxing Enterprise Development Co., Ltd., established on 1993-09-01, Business scope includes licensed projects:Various construction activities;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Marine and non-ship electromechanical equipment and accessories,Marine coating equipment,Marine engineering equipment,Electrical Equipment,Welding and cutting equipment,security equipment,Green facilities,Computer hardware and software,Network equipment,video surveillance system,metallic material,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),water-based paint(Removal of hazardous chemicals),Instrumentation,cable,ship material,textile,Rubber products,Fire supplies,Class I medical device,Sales of Class II Medical Devices;Marine metal piping and fittings,Processing of metal structural parts,Manufacturing and installation(Limited to branch operations),repair,debugging,Maintenance and Lease;General mechanical and electrical equipment maintenance;Production of fire fighting equipment(Limited to branch operations);Maintenance of marine machinery and equipment;Transformation of special vehicles,repair(Limited to branch operations);Production,Research and development of deck machinery(Limited to branch operations);ship refit,repair,manufacture(Limited to branch operations);ship design.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Hangzhou Zhongying Technology Group Co., Ltd., established on 2008-11-13, Business scope includes technology development:Environmental Technology,Biotechnology;Industrial Investment;Serve:investment management,Investment Advisory(ex-securities,futures)(Not approved by financial and other regulatory authorities,Not engage in financing deposits with the public,financing guarantee,Financial services such as wealth management on behalf of customers)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Glaxo Wellcome SA, a subsidiary of GSK Plc, is a company headquartered in Aranda de Duero, Spain. The firm manufactures and markets medicines.

Nippon Suisan produces and distributes seafood products. It offers fresh and frozen fish and other fish products including fish oil. It is a subsidiary of Nippon Suisan Kaisha Ltd. The company is headquartered in Tokyo, Japan.